Thursday, July 30, 2020

Biocon Biologics valued at $3.5 billion after Tata Capital's $30 million financing

Through investments in R&D and high-quality manufacturing infrastructure, we are confident of achieving our aspiration of serving 5 million patients through our biosimilars portfolio, CEO Hamachar said https://ift.tt/33dByn4 https://ift.tt/eA8V8J

No comments:

Post a Comment

Ox Alpha, a "stealth model" from an unknown AI lab with a 1M-token multimodal context and capacity for 100T tokens/day, goes viral after launching on OpenRouter (Rohail Saleem/Wccftech)

Rohail Saleem / Wccftech : Ox Alpha, a “stealth model” from an unknown AI lab with a 1M-token multimodal context and capacity for 100T to...